Skip to main content

C151 Pill - pink capsule/oblong, 13mm

Pill with imprint C151 is Pink, Capsule/Oblong and has been identified as Lamotrigine 150 mg. It is supplied by Cipla Limited.

Lamotrigine is used in the treatment of Bipolar Disorder; Lennox-Gastaut Syndrome; Seizure Prevention; Epilepsy; Seizures and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for C151

Lamotrigine 150 mg C151
Lamotrigine 150 mg C151

Lamotrigine

Imprint
C151
Strength
150 mg
Color
Pink
Size
13.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Triazine anticonvulsants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cipla Limited
National Drug Code (NDC)
69097-0151 (Discontinued)
Inactive Ingredients
lactose monohydrate, sodium starch glycolate type A potato, silicon dioxide, povidone k30, magnesium stearate, ferric oxide red, ferric oxide yellow, ferrosoferric oxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "C151"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.